Literature DB >> 1807753

The USC*PACK PC programs for population pharmacokinetic modeling, modeling of large kinetic/dynamic systems, and adaptive control of drug dosage regimens.

R W Jelliffe.   

Abstract

Programs for PC's and compatibles provide nonparametric (NPEM) population pharmacokinetic modeling, BOXES for compartments and arrows for pathways, to make large kinetic and dynamic models, and clinical software for Bayesian adaptive control of drug dosage regimens, with D-optimal sampling strategies and explicit determination of assay error patterns.

Mesh：

Year:  1991        PMID： 1807753      PMCID： PMC2247677     

Source DB:  PubMed          Journal:  Proc Annu Symp Comput Appl Med Care        ISSN： 0195-4210


  8 in total

1.  Building and evaluation of a structured representation of pharmacokinetics information presented in SPCs: from existing conceptual views of pharmacokinetics associated with natural language processing to object-oriented design.

Authors:  Catherine Duclos-Cartolano; Alain Venot
Journal:  J Am Med Inform Assoc       Date:  2003-01-28       Impact factor: 4.497

2.  Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models.

Authors:  Jurgen B Bulitta; Cornelia B Landersdorfer
Journal:  AAPS J       Date:  2011-03-04       Impact factor: 4.009

Review 3.  Benchmarking therapeutic drug monitoring software: a review of available computer tools.

Authors:  Aline Fuchs; Chantal Csajka; Yann Thoma; Thierry Buclin; Nicolas Widmer
Journal:  Clin Pharmacokinet       Date:  2013-01       Impact factor: 6.447

4.  Renal elimination of amikacin and the aging process.

Authors:  M Ducher; P Maire; C Cerutti; Y Bourhis; F Foltz; P Sorensen; R Jelliffe; J P Fauvel
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

5.  Should busulfan therapeutic range be narrowed in pediatrics? Experience from a large cohort of hematopoietic stem cell transplant children.

Authors:  M Philippe; S Goutelle; J Guitton; X Fonrose; C Bergeron; P Girard; Y Bertrand; N Bleyzac
Journal:  Bone Marrow Transplant       Date:  2015-09-21       Impact factor: 5.483

6.  Aminoglycoside dosages and nephrotoxicity: quantitative relationships.

Authors:  Florent Rougier; Michel Ducher; Michel Maurin; Stéphane Corvaisier; Daniel Claude; Roger Jelliffe; Pascal Maire
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  Population pharmacokinetics of lopinavir predict suboptimal therapeutic concentrations in treatment-experienced human immunodeficiency virus-infected children.

Authors:  Natella Rakhmanina; John van den Anker; Aline Baghdassarian; Steven Soldin; Keetra Williams; Michael N Neely
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

8.  Accurately Achieving Target Busulfan Exposure in Children and Adolescents With Very Limited Sampling and the BestDose Software.

Authors:  Michael Neely; Michael Philippe; Teresa Rushing; Xiaowei Fu; Michael van Guilder; David Bayard; Alan Schumitzky; Nathalie Bleyzac; Sylvain Goutelle
Journal:  Ther Drug Monit       Date:  2016-06       Impact factor: 3.681
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.